NCT02688712 2026-04-13ExIST Study of LY2157299 (Galunisertib) in Rectal CancerProvidence Health & ServicesPhase 2 Active not recruiting50 enrolled
NCT02452008 2025-12-19Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Active not recruiting60 enrolled